The signal
Western Australia has officially adopted the federal Therapeutic Goods Legislation Amendment (2026 Measures No. 1) Regulations, effective 18 September 2026, under the Therapeutic Goods Law Application Act 2024.
Who should care
Healthcare providers, pharmaceutical companies, medical device suppliers, and regulatory compliance officers in WA need to understand the changes to ensure their operations remain compliant with the updated regulatory framework.
What changed
On 18 September 2026, the WA government published the Therapeutic Goods (Legislative Instruments) Notice (No. 14) 2026, formally incorporating the federal Therapeutic Goods Legislation Amendment (2026 Measures No. 1) Regulations into state law. This means the amendments to the Therapeutic Goods Act 1989 as enacted federally are now legally applicable within WA, aligning state regulatory requirements with the national framework.
Want to follow this thread yourself? Search GovScanner's free dashboard, or connect GovScanner to your favourite AI so your model can explore WA government data for you.
The Notice operates under the Therapeutic Goods Law Application Act 2024, which enables WA to adopt federal therapeutic goods legislation and amendments, thereby streamlining regulatory oversight for therapeutic goods, including medicines and medical devices.
Why it matters
This adoption ensures WA’s regulatory environment for therapeutic goods matches the national standard, reducing legal complexity and compliance risks for companies operating in multiple jurisdictions. For healthcare providers and suppliers, this means updated obligations, potentially altered approval processes, and compliance requirements reflecting the latest federal measures.
Aligning with federal regulations can also affect timelines for product approvals, post-market surveillance, and reporting obligations. Regulatory compliance officers should review these changes promptly to mitigate risks of non-compliance penalties and to maintain uninterrupted supply and service.
For pharmaceutical companies and medical device suppliers, harmonisation can lower administrative burdens and support smoother interstate trade and product distribution.
Source trail
The adoption is documented in the Therapeutic Goods (Legislative Instruments) Notice (No. 14) 2026, which was published on 18 September 2026 under the Therapeutic Goods Law Application Act 2024. This legislation follows the framework established by WA’s 42nd Parliament and is administered by the Minister for Health.
For background on the enabling legislation, see the Gazette notice on the Minister’s appointment to administer the Therapeutic Goods Law Application Act 2024, and previous GovScanner coverage on WA’s adoption of federal therapeutic goods regulations.
Watch next
Stakeholders should monitor any guidance or compliance updates issued by WA Health following this adoption, especially any transitional provisions or deadlines for compliance. Watch for announcements on implementation steps or training sessions to assist providers and suppliers.
Further federal amendments or related regulations may also be adopted under this Act, so ongoing vigilance is recommended.
Find your own data
Want to explore this thread yourself? Search the free GovScanner dashboard, or connect GovScanner directly to your favourite AI so your model can investigate WA government data for you. It is quick to connect, and it gives your AI raw access to structured WA government records instead of making it hunt through PDFs and webpages from scratch.